|
TOPORS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41424674590962E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98907557091843E-12 |
| Normal-vs-Stage2 |
2.36190000890701E-09 |
| Normal-vs-Stage3 |
5.41580003066144E-10 |
| Normal-vs-Stage4 |
3.17280000050602E-08 |
| Stage1-vs-Stage2 |
9.488600E-01 |
| Stage1-vs-Stage3 |
8.844200E-01 |
| Stage1-vs-Stage4 |
3.891800E-01 |
| Stage2-vs-Stage3 |
9.279200E-01 |
| Stage2-vs-Stage4 |
5.156000E-01 |
| Stage3-vs-Stage4 |
6.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72761804861921E-12 |
| Normal-vs-AfricanAmerican |
3.67299968218049E-10 |
| Normal-vs-Asian |
1.50182999999471E-05 |
| Caucasian-vs-AfricanAmerican |
2.874200E-01 |
| Caucasian-vs-Asian |
7.700600E-01 |
| AfricanAmerican-vs-Asian |
5.088600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62703184258817E-12 |
| Normal-vs-Female |
5.83269998966074E-09 |
| Male-vs-Female |
3.588100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.93600000475413E-08 |
| Normal-vs-Extreme_Weight |
1.62880819942757E-12 |
| Normal-vs-Obese |
2.09590012012484E-10 |
| Normal-vs-Extreme_Obese |
1.95199999997175E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.871850E-01 |
| Normal_Weight-vs-Obese |
7.886400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.739000E-01 |
| Extreme_Weight-vs-Obese |
4.032100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.908000E-01 |
| Obese-vs-Extreme_Obese |
6.101600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.59489999999441E-05 |
| Normal-vs-Age(41-60Yrs) |
2.94779756160324E-11 |
| Normal-vs-Age(61-80Yrs) |
1.63224989080391E-12 |
| Normal-vs-Age(81-100Yrs) |
1.34759999825818E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.019600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.332200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.751600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.354470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.415440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.065000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62625468647093E-12 |
| Normal-VS-Type2 PRCC |
2.61113353161591E-12 |
| Normal-VS-KIRP CIMP |
6.196000E-03 |
| Normal-VS-Unclassified PRCC |
1.31399999991899E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.446400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.937600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.923400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.197600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.122800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.192000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.34849999447562E-08 |
| Normal-vs-N2 |
6.01340000017103E-07 |
| N0-vs-N1 |
1.277980E-01 |
| N0-vs-N2 |
2.409400E-01 |
| N1-vs-N2 |
1.213360E-01 |
|
|
